| 0910-0932 |
National Youth Tobacco Surveys 2024 2026 |
2025-10-29 |
| 0910-0929 |
A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising |
2024-12-02 |
| 0910-0928 |
Institutional Review Boards; Cooperative Research - PROPOSED RULE |
2024-03-21 |
| 0910-0927 |
Labeling Requirements for Approved or Conditionally Approved New Animal Drugs - Proposed rule. |
2024-03-07 |
| 0910-0926 |
PROPOSED RULE: Protection of Human Subjects and Institutional Review Boards; Harmonization with the Common Rule |
2024-02-13 |
| 0910-0925 |
Investigational New Drug Applications: Exemptions for Clinical Investigations to Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic. |
2023-11-07 |
| 0910-0924 |
Investigational New Drug Applications: Annual Reporting |
2023-11-07 |
| 0910-0923 |
Adding Requirement to Submit Mail Tracking Number for Articles of Food Arriving by International Mail and Timeframe for Post-Refusal and Post-Hold Submissions |
2025-12-08 |
| 0910-0922 |
Medical Devices--Voluntary Improvement Program |
2023-07-31 |
| 0910-0921 |
List of US Manufacturers of Specific CVM-Regulated Products with Interest in Exporting Covered Products to China |
2023-08-29 |
| 0910-0920 |
Quantitative Research on Front of Package Labeling on Packaged Foods |
2023-06-15 |
| 0910-0919 |
Assessing Physiological, Neural and Self-Reported Response to Tobacco Education Messages |
2023-05-05 |
| 0910-0918 |
Endorser Status and Actual Use in Direct-to-Consumer Television Ads |
2023-05-05 |
| 0910-0917 |
Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion |
2023-05-05 |
| 0910-0916 |
Perceptions of Prescription Drug Products with Medication Tracking Capabilities |
2023-05-09 |
| 0910-0915 |
The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study) |
2024-10-18 |
| 0910-0914 |
Monthly Monitoring Study |
2023-02-10 |
| 0910-0913 |
Tobacco Product Manufacturing Practice Requirements |
2023-03-13 |
| 0910-0912 |
Yale-Mayo Clinic Centers of Excellence in Regulatory Science and Innovation B12 Pediatric Device Survey |
2024-09-06 |
| 0910-0911 |
Substances Generally Recognized as Safe: Best Practices for Convening a GRAS Panel |
2022-11-01 |
| 0910-0910 |
Text Analysis of Proprietary Drug Name Interpretations |
2023-06-14 |
| 0910-0909 |
Standardized Reporting Forms for Federally Funded Public Health Projects and Agreements |
2024-01-22 |
| 0910-0908 |
Targeted Mechanism of Action Presentations in Prescription Drug Promotion |
2023-05-18 |
| 0910-0907 |
Study of How Consumers Use Flavors to Make Inferences About Electronic Nicotine Delivery System (ENDS) Product Qualities and Intentions to Use (Phase 2) |
2022-12-21 |
| 0910-0906 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases - FINAL RULE |
2024-07-03 |
| 0910-0905 |
Quantitative Research on a Voluntary Symbol Depicting the Nutrient Content Claim "Healthy" on Packaged Food |
2022-04-12 |
| 0910-0904 |
Compounding Animal Drugs from Bulk Drug Substances |
2025-07-30 |
| 0910-0903 |
Infant Formula Enforcement Discretion Policy |
2022-05-20 |
| 0910-0902 |
Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials |
2021-09-16 |
| 0910-0901 |
Medical Conference Attendees’ Observations about Prescription Drug Promotion |
2022-02-15 |
| 0910-0900 |
Study of Disclosures to Health Care Providers Regarding Data that Do Not Support Unapproved Use of an Approved Prescription Drug |
2022-07-29 |
| 0910-0899 |
Survey of Drug Product Manufacturing, Processing, and Packing Facilities |
2021-04-07 |
| 0910-0898 |
Laboratory Accreditation for Analyses of Foods |
2024-12-20 |
| 0910-0897 |
Study of Multiple Indications in Direct-to-Consumer Television Advertisements |
2021-09-20 |
| 0910-0896 |
Empirical Study of Promotional Implications of Proprietary Prescription Drug Names |
2021-03-22 |
| 0910-0895 |
Assessment of Terms and Phrases Commonly Used in Prescription Drug Promotion |
2022-01-20 |
| 0910-0894 |
Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion |
2020-12-08 |
| 0910-0893 |
Right to Try Act: Reporting Requirements |
2022-11-22 |
| 0910-0892 |
Health Care Providers Understanding of Opioid Analgesic Abuse-Deterrent Formulations: Phase 2 and 3 Surveys |
2021-06-09 |
| 0910-0891 |
Generic Clearance for Qualitative Data to Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed |
2023-08-08 |
| 0910-0890 |
Healthcare Provider Perception of Boxed Warning Information Survey |
2020-10-26 |
| 0910-0889 |
Accreditation Scheme for Conformity Assessment Program |
2023-06-30 |
| 0910-0888 |
Importation of Prescription Drugs |
2023-10-20 |
| 0910-0887 |
Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey |
2021-06-16 |
| 0910-0886 |
Requests for Nonbinding Feedback After Certain FDA Inspections of Device Establishments |
2022-10-04 |
| 0910-0885 |
Study of Oncology Indications in Direct-to-Consumer Television Advertising |
2021-04-05 |
| 0910-0884 |
List of US Manufacturers of Specific CVM-Regulated Products with Interest in Exporting Covered Products to China |
2020-09-24 |
| 0910-0883 |
Obtaining Information to Understand and Challenges and Opportunities Encountered by Compounding Outsourcing Facilities |
2025-06-18 |
| 0910-0882 |
Collection of Conflict of Interest Information for Participation in Food and Drug Administration Non-Employee Fellowship and Traineeship Programs |
2022-12-21 |
| 0910-0881 |
Web-Based Pilot Survey to Assess Allergy to Cosmetics in the United States |
2019-12-06 |
| 0910-0880 |
Experimental Study on Measuring Consumer Comprehension of Displays of Harmful and Potentially Harmful Constituents (HPHCs) in Tobacco Products and Tobacco Smoke |
2020-09-17 |
| 0910-0879 |
Premarket Tobacco Product Applications and Recordkeeping Requirements |
2024-11-27 |
| 0910-0878 |
Sunlamp Products; Proposed Amendment to § 1002.1 (Record and Reporting Requirements) and § 1040.20 (Performance Standard) |
2019-10-01 |
| 0910-0877 |
Required Warnings for Cigarette Packages and Advertisements |
2023-04-21 |
| 0910-0876 |
Generic Clearance for Quick Turnaround Testing of Communication Effectiveness |
2026-02-19 |
| 0910-0875 |
Physician Interpretation of Information About Prescription Drugs in Scientific Publications vs. Promotional Pieces |
2020-06-02 |
| 0910-0874 |
Disease Awareness and Prescription Drug Promotion on Television |
2020-01-28 |
| 0910-0873 |
Investigation of Consumer Perceptions of Expressed Modified Risk Claims |
2018-10-30 |
| 0910-0872 |
Experimental Study of an Accelerated Approval Disclosure |
2022-11-22 |
| 0910-0871 |
Obtaining Information for Evaluating Nominated Bulk Drug Substances for Use in Compounding Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
2019-05-09 |
| 0910-0870 |
Electronic Format for Submissions; Promotional Labeling and Advertising Materials for Human Prescription Drugs |
2019-05-09 |
| 0910-0869 |
Healthcare Professional Survey of Professional Prescription Drug Promotion |
2019-03-11 |
| 0910-0868 |
Assessment of Combination Product Review Practices |
2019-02-14 |
| 0910-0867 |
Survey of Current Manufacturing Practices for the Cosmetics Industry |
2018-11-29 |
| 0910-0866 |
Experimental Study of Cigarette Warnings |
2018-12-21 |
| 0910-0865 |
Generic Clearance for Quantitative Testing for the Development of FDA Communications (HFP) |
2025-05-05 |
| 0910-0864 |
Disclosures of Descriptive Presentation in Professional Oncology Prescription Drug Promotion |
2018-11-15 |
| 0910-0863 |
Surveys and Interviews with Investigational New Drug Sponsors to Assess Current Communication Practices with FDA Review Staff Under the Sixth Authorization of the Prescription Drug User Fee Act |
2018-11-19 |
| 0910-0862 |
Labeling of Red Blood Cell Units with Historical Antigen Typing Results |
2018-10-23 |
| 0910-0861 |
Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads |
2019-07-24 |
| 0910-0860 |
Disclosures in Professional and Consumer Prescription Drug Promotion |
2018-08-10 |
| 0910-0859 |
Drug Supply Chain Security Act (DSCSA) Pilot Progam |
2018-08-10 |
| 0910-0858 |
Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act |
2024-09-24 |
| 0910-0857 |
GFI: Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities Questions and Answers |
2021-07-29 |
| 0910-0856 |
Medical Product Communications That Are Consistent With the Food and Drug Administration Required Labeling -Questions and Answers |
2021-07-29 |
| 0910-0855 |
National Agriculture and Food Defense Strategy Survey |
2024-08-15 |
| 0910-0854 |
Quality Facility Attestation |
2018-06-13 |
| 0910-0853 |
Utilization of Adequate Provision Among Low to Non-Internet Users |
2018-03-16 |
| 0910-0852 |
Transfer of a Premarket Notification Clearance |
2018-03-14 |
| 0910-0851 |
Evaluation of the Food and Drug Administration’s Point-of-Sale Campaign |
2019-02-27 |
| 0910-0850 |
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based in Vitro Diangostics |
2021-02-25 |
| 0910-0849 |
Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion |
2017-12-14 |
| 0910-0848 |
Experimental Study on Warning Statements for Cigarette Graphic Health Warnings |
2017-09-19 |
| 0910-0847 |
Data To Support Social and Behavioral Research as Used by the Food and Drug Administration |
2026-02-20 |
| 0910-0846 |
Character-Space-Limited Online Prescription Drug Communications |
2017-08-16 |
| 0910-0845 |
Draft Guidance for Industry; How to Prepare a Pre-Request for Designation (Pre-RFD) |
2017-07-26 |
| 0910-0844 |
Medical Device De Novo Classification Process |
2025-01-03 |
| 0910-0843 |
GFI: E6(R2) Good Clinical Practice; International Council for Harmonisation |
2020-08-10 |
| 0910-0842 |
Import Trade Auxiliary Communication System |
2017-06-26 |
| 0910-0841 |
Donor Risk Assessment Questionnaire for the FDA/National Heart, Lung, and Blood Institute - Sponsored Transfusion-Transmissible Infections Monitoring System - Risk Factor Elicitation |
2022-02-14 |
| 0910-0840 |
Voluntary Qualified Importer Program |
2024-07-15 |
| 0910-0839 |
Establishing and Maintaining a List of U.S. Milk and Milk Product, Seafood,Infant Formula, and Formula for Young Children Manufacturers/Processorswith Interest in Exporting to China |
2017-12-05 |
| 0910-0838 |
Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements |
2009-08-31 |
| 0910-0837 |
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species |
2006-12-07 |
| 0910-0836 |
REPORTING INFORMATION REGARDING FALSIFICATION OF DATA |
2010-03-30 |
| 0910-0835 |
Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner |
2010-04-19 |
| 0910-0834 |
Postmarketing Safety Reporting for Combination Products |
2020-08-31 |
| 0910-0833 |
Food and Drug Administration Advisory Committee Regulations |
2023-06-30 |
| 0910-0832 |
Certification of Identity for Freedom of Information and Privacy Act Requests |
2023-05-03 |
| 0910-0831 |
STUDY: Superimposed Text in Direct-to-Consumer Promotion of Prescription Drugs |
2017-01-26 |
| 0910-0830 |
Tobacco Product Standard: NNN Level of Finished Smokeless Tobacco Products |
2017-01-25 |
| 0910-0829 |
Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Inlcuding Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Proposed Rule |
2016-11-30 |
| 0910-0828 |
National Survey of Health Information and Communication |
2017-07-28 |
| 0910-0827 |
Guidance for Industry (GFI): Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
2019-11-04 |
| 0910-0826 |
Animation in Direct-to-Consumer Advertising |
2016-10-26 |
| 0910-0825 |
Restricted Sale, Distribution, and Use of Sunlamp Products |
2016-09-13 |
| 0910-0824 |
Market Claims in Direct-to-Consumer Prescription Drug Print Ads |
2017-02-14 |
| 0910-0823 |
Medical Device Accessories |
2025-09-11 |
| 0910-0822 |
Tropical Disease Priority Review Vouchers |
2025-07-30 |
| 0910-0821 |
Quantitative Information in Direct-to-Consumer Television Advertisements Survey |
2018-05-04 |
| 0910-0820 |
Comparing Food Safety Knowledge, Attitude and Behavior Among English-Dominant Hispanics, Spanish-Dominant Hispanics, and Other Consumers |
2016-04-20 |
| 0910-0819 |
Experimental Study on Consumer Perceptions of Modified Risk Tobacco Products (MRTP) |
2016-02-02 |
| 0910-0818 |
Hearing, Aging, and Direct-to-Consumer Television Advertisements |
2016-01-13 |
| 0910-0817 |
Gluten-Free Labeling of Fermented or Hydrolyzed Foods |
2020-08-13 |
| 0910-0816 |
Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption - Agricultural Water - FINAL RULE |
2024-04-30 |
| 0910-0815 |
National Panel of Tobacco Consumer Studies |
2020-04-28 |
| 0910-0814 |
Individual Patient Expanded Access Applications |
2023-09-07 |
| 0910-0813 |
Food Labeling: Revision of the Nutrition Facts Label and Supplement Facts Label |
2019-07-22 |
| 0910-0812 |
Mitigation Strategies to Protect Food Against Intentional Adulteration |
2025-09-30 |
| 0910-0811 |
Exempt Infant Formula Production: Current Good Manufacturing Practices (CGMPs), Quality Control Procedures, Conduct of Audits, and Records |
2016-01-28 |
| 0910-0810 |
Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications |
2024-12-27 |
| 0910-0808 |
Food and Drug Administration's Research and Evaluation Survey for the Public Education Campaign on Tobacco among LGBT (RESPECT) |
2018-12-12 |
| 0910-0807 |
Voluntary Labeling Indicating Whether Foods Have or Have Not BeenDerived from Genetically Engineered Plants |
2015-12-09 |
| 0910-0806 |
Pharmaceutical Distribution Supply Chain |
2025-05-02 |
| 0910-0805 |
Electronic User Fee Payment Form Requests |
2024-11-01 |
| 0910-0803 |
Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Ads |
2015-06-29 |
| 0910-0802 |
Guidance for Industry on Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants |
2015-06-25 |
| 0910-0801 |
Survey of Pharmacists and Patients; Variations in the Physical Characteristics of Generic Drug Pills and Patients' Perceptions |
2015-05-28 |
| 0910-0800 |
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act |
2026-03-27 |
| 0910-0799 |
Survey on the Occurrence of Foodborne Illness Risks Factors in Selected Institutional Foodservice and Retail Food Stores Facility Types (2015-2025) |
2021-08-25 |
| 0910-0797 |
Guidance for Industry on Controlled Correspondence Related to Generic Drug Development |
2020-04-28 |
| 0910-0796 |
Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications |
2024-07-05 |
| 0910-0795 |
Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use - Final Rule |
2015-06-03 |
| 0910-0794 |
Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products - Proposed Rule |
2014-12-30 |
| 0910-0793 |
Food and Cosmetic Export Certificates |
2024-08-09 |
| 0910-0792 |
Food Allergen Labeling and Reporting |
2025-02-07 |
| 0910-0791 |
Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements |
2015-10-21 |
| 0910-0790 |
Survey of Health Care Practitioners for Device Labeling Format and Content |
2015-04-14 |
| 0910-0789 |
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals |
2018-09-13 |
| 0910-0788 |
Evaluation of the Food and Drug Administration's 'Fresh Empire' Multicultural Youth Tobacco Prevention Campaign. |
2019-02-12 |
| 0910-0787 |
Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings with the Office of Orphan Products Development |
2018-03-08 |
| 0910-0786 |
Abbreviated New Drug Applications and 505(b)(2) Applications |
2016-10-06 |
| 0910-0785 |
Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements |
2015-10-21 |
| 0910-0784 |
Risk and Benefit Perception Scale Development |
2015-10-19 |
| 0910-0783 |
Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments |
2016-06-27 |
| 0910-0782 |
Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments |
2021-04-14 |
| 0910-0781 |
Information Request Regarding pH of Smokeless Tobacco Products |
2014-11-10 |
| 0910-0780 |
Application for Participation in the Food and Drug Administration Commissioner's Fellowship Program |
2024-01-16 |
| 0910-0779 |
Antiparasitic Drug Use and Antiparasitic Resistance Survey |
2014-07-11 |
| 0910-0778 |
Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents |
2015-10-01 |
| 0910-0777 |
Guidance for Industry on Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
2017-10-17 |
| 0910-0776 |
Registration of Human Drug Compounding Outsourcing Facilities under section 503B of the FFDCA and Associated fees under section 744K |
2023-12-01 |
| 0910-0775 |
Guidance for Industry on Establishing That a Tobacco Product Was Commercially Marketed in the United States As of February 15, 2007 |
2025-09-30 |
| 0910-0774 |
Experimental Study of Proposed Changes to the Nutrition Facts Label Formats |
2014-09-02 |
| 0910-0773 |
Sanitary Transportation of Human and Animal Food |
2025-09-30 |
| 0910-0772 |
Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing |
2014-06-30 |
| 0910-0771 |
Providing Waiver-Related Materials in Accordance with Draft Guidance for Industry on Providing Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format |
2017-08-18 |
| 0910-0770 |
Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements - Final Rule |
2014-11-10 |
| 0910-0769 |
Submission to CDRH Allegations of Regulatory Misconduct Associated with Medical Devices |
2023-10-12 |
| 0910-0768 |
Deeming Tobacco Products To Be Subject to the FD&C Act |
2022-10-25 |
| 0910-0767 |
Annual Reporting for Custom Device Exemption |
2020-08-31 |
| 0910-0766 |
Safety Assurance Case |
2014-04-10 |
| 0910-0765 |
Guidance for Industry (GFI): Expedited Programs for Serious Conditions-Drugs and Biologics |
2024-08-23 |
| 0910-0764 |
Study; Consumer Responses to Nutrition Facts Labels w/Various Footnote Formats and Declaration of Added Sugars |
2013-06-10 |
| 0910-0763 |
Experimental Studies on Consumer Responses to Nutrient Content Claims on Fortified Foods |
2013-08-26 |
| 0910-0762 |
Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug and Cosmetic Act |
2017-03-21 |
| 0910-0761 |
Eye Tracking Experimental Studies to Explore Consumer Use of Food Labeling Information and Consumer Response to Online Surveys |
2013-07-16 |
| 0910-0760 |
Federal-State Regulatory Program Standards |
2026-03-24 |
| 0910-0759 |
Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products; Proposed Rule |
2018-07-26 |
| 0910-0758 |
Final Guidance for Industry on Chemistry, Manufacturing, and Controls Postapproval Manufacturing Changes to be Documented in Annual Reports |
2013-11-06 |
| 0910-0757 |
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Proposed Rule |
2013-12-06 |
| 0910-0756 |
Requests for Feedback on Medical Device Submissions |
2026-02-27 |
| 0910-0755 |
Protection of Human Subjects: Informed Consent; Institutional Review Boards |
2016-11-15 |
| 0910-0754 |
Mailing of Important Information About Drugs |
2022-12-19 |
| 0910-0753 |
Evaluation of the Food and Drug Administrations's General Market Youth Tobacco Prevention Campaign |
2022-04-07 |
| 0910-0752 |
Foreign Supplier Verification Programs for Importers of Food for Humans and Animals |
2025-07-29 |
| 0910-0751 |
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls For Human Food and Food for Animals |
2024-10-29 |
| 0910-0750 |
Accreditation of Third-Party Certification Bodies to Conduct Food Safety Audits and Issue Certifications |
2025-09-30 |
| 0910-0749 |
Tobacco Products, User Fees, Requirements for the Submission of Data Needed to Calculate User Fees for Domestic Manufacturers and Importers of Tobacco Products |
2025-07-30 |
| 0910-0748 |
Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations |
2020-05-28 |
| 0910-0747 |
Experimental Study on Consumer Responses to Whole Grain Labeling Statements on Food Packages |
2014-05-20 |
| 0910-0746 |
Review Transparency & Communication for New Molecular Entity NDAs & Original BLAs in Prescription Drug User Fee Act |
2022-08-31 |
| 0910-0745 |
Tobacco Retailer Training Programs |
2026-02-27 |
| 0910-0744 |
Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types (2013) |
2024-08-30 |
| 0910-0743 |
Communicating Composite Scores in Direct-to-Consumer (DTC) Prescription Drug Advertising |
2013-05-16 |
| 0910-0742 |
Proposed Amendment to Laser Product Performance Standard |
2013-06-25 |
| 0910-0741 |
Human Subject Protection; Acceptance of Data from Clinical Studies for Medical Devices |
2018-03-15 |
| 0910-0740 |
Medical Devices: Use of Certain Symbols in Labeling--Glossary to Support the Use of Symbols in Labeling |
2019-09-17 |
| 0910-0739 |
Product Safety Standards--Recordkeeping and Third Party Disclosure Requirements |
2013-01-30 |
| 0910-0738 |
Guidance for Center for Devices and Radiological Health Appeals Processes |
2025-12-04 |
| 0910-0737 |
Experimental Study: Examination of Corrective Direct-to-Consumer Television Advertising |
2014-02-03 |
| 0910-0736 |
Experimental Study on the Public Display of Lists of Harmful and Potential Harmful Tobacco Constituents |
2013-01-17 |
| 0910-0735 |
Experimental Study on Consumer Responses to Labeling Statements on Food Packages |
2012-05-01 |
| 0910-0734 |
Safety Labeling Changes; Implementation of the Federal Food, Drug, and Cosmetic Act |
2019-06-26 |
| 0910-0733 |
Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring |
2019-06-26 |
| 0910-0732 |
Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act |
2025-09-30 |
| 0910-0731 |
Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products |
2025-09-19 |
| 0910-0730 |
Health Care Professional Survey of Prescription Drug Promotion |
2012-10-12 |
| 0910-0729 |
Secure Supply Chain Pilot Program (SSCPP) |
2012-06-28 |
| 0910-0728 |
Labeling of Certain Beers Subject to the Labeling Jurisdiction of the FDA |
2021-12-20 |
| 0910-0727 |
Generic Drug User Fee Program |
2025-06-18 |
| 0910-0726 |
Improving Food Safety and Defense Capacity of the State and Local Level: Review of State and Local Capacities |
2015-11-30 |
| 0910-0725 |
Experimental Study; Health Claims and Disclaimers About the Relationship Between Selenium and Risk of Various Cancers |
2012-09-21 |
| 0910-0724 |
Experimental Study: Disease Information in Branded Promotional Material |
2012-11-27 |
| 0910-0723 |
Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma |
2012-05-07 |
| 0910-0722 |
Medical Device Decision Analysis: A Risk-Tolerance Pilot Study |
2012-07-05 |
| 0910-0721 |
Animal Food Labeling; Declaration of Certifiable Color Additives |
2021-07-12 |
| 0910-0720 |
Unique Device Identification System |
2020-02-13 |
| 0910-0719 |
General Licensing Provisions; Section 351(k) Biosimilar Applications |
2021-01-27 |
| 0910-0718 |
Biosimilar User Fee Program |
2025-01-31 |
| 0910-0717 |
SPF Labeling and Testing Requirements for OTC Sunscreen Products |
2019-02-28 |
| 0910-0716 |
Potential Tobacco Product Violations Reporting Form |
2023-07-24 |
| 0910-0715 |
Survey of "Health Care Providers' Responses to Medical Device Labeling" |
2012-03-08 |
| 0910-0714 |
Examination of Online Direct-to-Consumer Prescription Drug Promotion |
2012-12-07 |
| 0910-0713 |
Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions |
2013-01-18 |
| 0910-0712 |
Data to Support Communications Usability Testing, as Used by the Food and Drug Administration |
2011-08-25 |
| 0910-0711 |
Real Time Surveys of Consumers` Knowledge, Perceptions and Reported Behavior Concerning Foodborne Illness Outbreaks or Food Recalls |
2011-06-27 |
| 0910-0710 |
Data to Support Food and Nutrition Product Communications as Used by the Food and Drug Administration |
2011-05-27 |
| 0910-0709 |
Changes to Reportable Food Registry Reports Under the FDA Food Safety Modernization Act |
2012-05-16 |
| 0910-0708 |
Data to Support Communications to Educate Consumers on How to Safely Purchase Drugs Online |
2011-11-01 |
| 0910-0707 |
Experimental Study of Comparative Direct-to-Consumer (DTC) Advertising |
2013-07-23 |
| 0910-0706 |
Comparing Nutrition Knowledge, Attitude, and Behavior Among English Dominant Hispanics, Spanish Dominant Hispanics, and Other Consumers |
2012-06-28 |
| 0910-0705 |
Section 513(g) Requests for Information |
2021-05-17 |
| 0910-0704 |
Guidance on Consultation Procedures: Foods Derived From New Plant Varieties |
2018-03-28 |
| 0910-0703 |
Experimental Study of Format Variations in the Brief Summary of Direct-to-Consumer (DTC) Print Advertisements |
2012-11-06 |
| 0910-0702 |
Orphan Drug Regulations |
2013-06-18 |
| 0910-0701 |
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic: Agency Guidance |
2020-06-24 |
| 0910-0700 |
Guidance Medical Device ISO 13485: 2003 Voluntary Audit Report Submission Pilot Program |
2015-01-12 |
| 0910-0699 |
Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance |
2012-12-19 |
| 0910-0698 |
National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products |
2011-07-05 |
| 0910-0697 |
Qualitative Feedback on Food and Drug Administration Service Delivery |
2023-11-28 |
| 0910-0696 |
Followup Study for Infant Feeding Practices Study II |
2012-02-17 |
| 0910-0695 |
Request for Generic Clearance of FDA, Testing Communications On Drugs |
2024-03-07 |
| 0910-0694 |
SPF Labeling and Testing Requirements for OTC Sunscreen Products with SPF Values Greater Than 50 |
2011-06-30 |
| 0910-0693 |
Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products |
2017-08-17 |
| 0910-0692 |
Study of Clinical Efficacy Information in Professional Labeling and Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs |
2011-03-20 |
| 0910-0691 |
Experimental Study of Patient Information Prototypes |
2011-01-31 |
| 0910-0690 |
Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products |
2012-02-03 |
| 0910-0689 |
TESTING COMMUNICATIONS ON FDA-REGULATED PRODUCTS USED IN ANIMALS |
2011-01-03 |
| 0910-0688 |
Time and Extent Applications for Nonprescription Drug Products |
2023-12-14 |
| 0910-0687 |
Testing Communications on Biological Products |
2014-12-04 |
| 0910-0686 |
Prescription Drug Advertisements; Presentation of Advertisements in Television and Radio - Final Rule |
2025-01-07 |
| 0910-0685 |
Information Request Regarding Dissolvable Tobacco Products |
2011-03-10 |
| 0910-0684 |
Tobacco Products, Exemptions From Substantial Equivalence Requirements |
2025-09-22 |
| 0910-0683 |
Information Required in Prior Notice of Imported Food |
2011-03-30 |
| 0910-0682 |
Experimental Study of Nutrition Facts Label Formats |
2011-07-28 |
| 0910-0681 |
Use of Serological Tests to Reduce the Risk of Transfusion-Transmitted Infection in Whole Blood and Blood Components; Agency Guidance |
2020-06-23 |
| 0910-0680 |
Tracking Network for PETNet, LivestockNet, and SampleNet |
2023-04-14 |
| 0910-0679 |
Guidance for Industry on Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act |
2017-04-25 |
| 0910-0678 |
Testing Communications On Medical Devices and Radiation-Emitting Products |
2026-05-29 |
| 0910-0677 |
Focus Groups About Drug Products As Used by The Food and Drug Administration |
2020-01-10 |
| 0910-0675 |
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products |
2020-04-27 |
| 0910-0674 |
Pretesting of Tobacco Communications |
2014-06-23 |
| 0910-0673 |
Substantial Equivalence Reports for Tobacco Products |
2024-11-26 |
| 0910-0672 |
Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans |
2016-10-24 |
| 0910-0671 |
Warning Plans for Smokeless Tobacco Products |
2026-01-28 |
| 0910-0670 |
Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims |
2019-12-05 |
| 0910-0669 |
Abbreviated New Animal Drug Applications |
2022-09-27 |
| 0910-0668 |
Experimental Study of Graphic Cigarette Warning Labels |
2012-12-05 |
| 0910-0667 |
Current Good Manufacturing Practices for Positron Emission Tomography Drugs |
2025-12-30 |
| 0910-0666 |
Revision of the Requirements for Constituent Material |
2013-06-13 |
| 0910-0665 |
Section 4205 of the Patient Protection and Affordable Care Act Restaurant Menu Labeling; Recordkeeping and Mandatory Third Party Disclosure |
2011-01-31 |
| 0910-0664 |
Section 4205 of the Patient Protection and Affordable Care Act ( P.L. 111-148: Restaurant Menu Labeling : Registration For Small Chains |
2011-01-31 |
| 0910-0663 |
Experimental Study: Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer (DTC) Television and Print Advertisements for Prescription Drugs |
2010-02-02 |
| 0910-0662 |
Information Request Regarding Menthol in Cigarettes |
2010-05-14 |
| 0910-0661 |
Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements |
2019-08-08 |
| 0910-0660 |
Production, Storage, and Transportation of Shell Eggs (preventing Salmonella Enteritidis (SE)) |
2025-09-30 |
| 0910-0659 |
Antimicrobial Animal Drug Sales and Distribution |
2025-05-12 |
| 0910-0658 |
Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water |
2025-05-02 |
| 0910-0657 |
Evaluation of Potential Sources for the Sentinel Initiative |
2009-09-10 |
| 0910-0656 |
Gluten-Free Labeling of Food Products Expermental Study |
2010-03-04 |
| 0910-0655 |
Experimental Studies of Nutrition Symbols on Food Packages |
2010-05-24 |
| 0910-0654 |
Tobacco Health Document Submission |
2025-09-19 |
| 0910-0653 |
Expanded Access to Investigational Drugs for Treatment Use |
2009-09-08 |
| 0910-0652 |
Experimental Study: Toll-Free Number for Consumer Reporting of Drug Product Side Effects in Direct-to-Consumer Television Advertisements for Prescription Drugs |
2009-09-10 |
| 0910-0651 |
Charging for Investigation Drugs under an IND |
2009-09-08 |
| 0910-0650 |
Tobacco Product Establishment Registration and Submission of Certain Health Information |
2025-09-15 |
| 0910-0649 |
Mental Models Study of Health Care Providers' Understanding of Prescription Drug Effectiveness |
2009-04-14 |
| 0910-0648 |
PDUFA Pilot Project Proprietary Name Review |
2009-07-01 |
| 0910-0647 |
Tobacco Product Standard on Flavored Cigarettes |
2010-03-31 |
| 0910-0646 |
Authorized Generic Drugs |
2013-09-12 |
| 0910-0645 |
FDA Adverse Event Reports; Electronic Submissions |
2021-09-14 |
| 0910-0644 |
Survey to Evaluate FDA's Food Defense Awareness Initiative ALERT |
2009-04-02 |
| 0910-0643 |
Third Party Disclosure and Recordkeeping Requirements For Reportable Food |
2023-10-25 |
| 0910-0642 |
Labeling of Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act |
2016-01-12 |
| 0910-0641 |
Labeling of Nonprescription Human Drug Products Marketed w/o an Approved App as Required by the Dietary Supp & Nonpresription Drug Consumer Protection Act |
2019-06-04 |
| 0910-0639 |
Mental Models Study of Farmers' Understanding and Implementation of Good Agricultural Practices |
2009-04-02 |
| 0910-0638 |
Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices |
2014-11-10 |
| 0910-0637 |
Survey to Evaluate the Effectiveness of Mississippi Delta Fish Advisories |
2009-03-16 |
| 0910-0636 |
Guide for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drugs Without an Approved Application |
2015-07-02 |
| 0910-0635 |
Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act |
2016-02-18 |
| 0910-0634 |
Experimental Evaluation of the Impact of Distraction |
2009-01-06 |
| 0910-0633 |
Guidance on Labeling for Natural Rubber Latex Condoms |
2021-05-26 |
| 0910-0632 |
Implementation of the Animal Generic Drug User Fee Act of 2008; User Fee Cover Sheet Form FDA 3728 ( 21 U.S.C. 379j - 21) Emergency Request |
2017-06-23 |
| 0910-0631 |
Mental Models Study of Communicating with Health Care Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women with Chronic Conditions |
2008-09-17 |
| 0910-0630 |
Requirements for Submission of In Vivo Bioequivalence Data; Final Rule |
2014-12-23 |
| 0910-0629 |
Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics |
2018-02-13 |
| 0910-0628 |
Survey of Current Manufacturing Practices in the Food Industry |
2007-09-30 |
| 0910-0627 |
Substances Prohibited From Use in Animal Food or Feed; Final Rule - 21 CFR Part 589 |
2024-03-28 |
| 0910-0626 |
Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act |
2015-02-23 |
| 0910-0625 |
Implementation of Sections 222,223,and 224 of the Food and Drug Administration Act of 2007 |
2025-08-29 |
| 0910-0624 |
Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Pregnancy and Lactation Labeling - Proposed Rule |
2018-02-27 |
| 0910-0623 |
Request for Designation as Country not Subject to the Restrictions Applicable to Human Food and Cosmetics Manufactured from, Processed With, or Otherwise Containing, Material from Cattle |
2024-01-26 |
| 0910-0622 |
Foreign Clinical Studies Not Conducted Under an IND |
2013-06-14 |
| 0910-0621 |
Voluntary National Retail Food Regulatory Program Standards |
2023-09-20 |
| 0910-0620 |
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species - Final Rule |
2020-07-24 |
| 0910-0618 |
Mental Models Study of Food Terrorism Risk Awareness |
2007-07-31 |
| 0910-0617 |
Survey of Food Safety and Nutrition Information Provided to Pregnant Women by Health Care Providers and WIC Educators |
2007-04-15 |
| 0910-0616 |
Certification to Accompany Drug, Biological Product, and Device Applications or Submissions |
2021-03-03 |
| 0910-0615 |
FDA Survey of Physicians' Perceptions of the Impact of Early Risk Communication about Medical Products |
2007-07-31 |
| 0910-0614 |
Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile |
2020-11-25 |
| 0910-0613 |
Medical Device User Fee Amendments of 2007; Foreign Small Business Certification Form FDA 3602 A |
2008-04-23 |
| 0910-0612 |
Label Comprehension Study |
2007-07-10 |
| 0910-0611 |
Experimental Evaluation of Variations in Content & Format of the Brief Summery in D-T-C Print Advertisements for Prescription Drugs |
2007-05-10 |
| 0910-0610 |
CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increadsed Risk of Transmitting HCV Infection ("Lookback") |
2007-09-05 |
| 0910-0609 |
Guide to Minimize Food Safety Hazards for Fresh-cut Fruits and Vegetables |
2014-01-28 |
| 0910-0608 |
Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: CGMP in Manufacturing, Packaging, Labeling or Holding Operations for Dietary Supplements |
2018-07-16 |
| 0910-0607 |
Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization ( 42 CFR 493.17) |
2025-11-26 |
| 0910-0606 |
Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements |
2023-05-11 |
| 0910-0605 |
New Animal Drugs for Minor Use and Minor Species |
2023-07-05 |
| 0910-0604 |
Pharmaceutical Development Study |
2007-06-20 |
| 0910-0603 |
Toll-Free Number for Consumer Reporting of Drug Product Side Effects: Comprehension |
2007-02-22 |
| 0910-0602 |
Use of Materials Derived from Cattle in Medical Products Intended for Use in Humans and Drugs Intended for Use in Ruminants |
2007-03-01 |
| 0910-0601 |
Manufactured Food Regulatory Program Standards |
2025-09-15 |
| 0910-0600 |
Supplements and Other Changes to Approved New Animal Drug Applications - Final Rule |
2007-03-08 |
| 0910-0599 |
Cosmetic Labeling Regulations |
2024-12-26 |
| 0910-0598 |
Guidance for Industry and FDA Staff; Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications; Availability |
2019-08-16 |
| 0910-0597 |
Recordkeeping Requirements for Human Food and Cosmetics Manufactured from, Processed With, or Otherwise Containing, Material from Cattle |
2011-11-14 |
| 0910-0596 |
Survey of Need for Online Medical Device Information |
2006-07-12 |
| 0910-0595 |
Guidance: Emergency Use Authorization of Medical Products |
2025-12-04 |
| 0910-0594 |
Guidance for Industry and FDA Staff; Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle |
2024-08-09 |
| 0910-0593 |
MedWatch - The FDA Safety Information and Adverse Event Reporting Program; Proposal to Survey MedWatch Partners Organizations - Survey |
2006-06-08 |
| 0910-0592 |
Experimental Study of Qualified Health Claims: Consumer Inferences About Monounsaturated Fatty Acids from Olive Oil, EPA and DHA Omega-3 Fatty Acids, and Green Tea |
2006-05-31 |
| 0910-0591 |
Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs: Study 1 |
2006-04-27 |
| 0910-0588 |
Survey of Healthcare Practitioners Regarding Their Preferences for Public Health Notifications |
2006-03-31 |
| 0910-0586 |
Medical Devices; Exception from General Requirements for Informed Consent |
2017-08-22 |
| 0910-0585 |
Medical Gas Containers and Closures: Current Good Manufacturing Practice Requirements; Proposed Rule |
2017-02-02 |
| 0910-0584 |
Guidance for Reagents for Detection of Specific Novel Influenza A Viruses |
2025-11-17 |
| 0910-0583 |
Recommendations for Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use |
2024-07-29 |
| 0910-0582 |
Guidance on Informed Consent for in Vitro Diagnostic Studies Using Leftover Human Specimens that are not Individually Identifiable |
2019-08-08 |
| 0910-0581 |
Guidance for Industry: Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees |
2021-09-30 |
| 0910-0580 |
The Mammography Quality Standards Act Final Regulations: Modifications and Aditions to Policy Guidance Help System #9 |
2005-12-29 |
| 0910-0579 |
Research Study Complaint Form |
2005-12-22 |
| 0910-0578 |
Voluntary Hazard Analysis and Critical Control Point Manuals for Operators and Regulators of Retail and Food Service Establishments |
2009-03-30 |
| 0910-0577 |
Reprocessed Single-Use Device Labeling |
2018-04-13 |
| 0910-0575 |
Waivers of Invivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form and Type A Medicated Articles |
2015-04-24 |
| 0910-0574 |
Survey on Program Funding |
2005-10-11 |
| 0910-0572 |
Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products, Final Rule |
2025-01-31 |
| 0910-0571 |
Guidance for Requesting an Extension to Use Existing Label Stock After The Trans Fat Labeling Effective Date of January 1, 2006 |
2006-04-12 |
| 0910-0570 |
Experimental Study of Carbohydrate Content Claims on Food Labels |
2006-03-15 |
| 0910-0569 |
Requests for Inspection by an Accredited Person under the Inspection by Accredited Persons Program |
2018-04-13 |
| 0910-0567 |
Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Products |
2005-05-16 |
| 0910-0566 |
Dispute Resolution Procedures for Science Based Decisions on Products Regulated by the CVM |
2021-02-23 |
| 0910-0565 |
Experimental Study of Health Claims on Food Packages |
2005-04-28 |
| 0910-0564 |
Performance Standard for Diagnostic X-Ray Systems and Their Major Components |
2005-03-29 |
| 0910-0563 |
Guidance for Industry: Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice |
2021-04-14 |
| 0910-0562 |
Channels of Trade Policy for Commodities with Residues of Pesticide Chemicals for Which Tolerances Have Been Rovoked, Suspended, or Modified by the EPA |
2023-12-13 |
| 0910-0560 |
Recordkeeping and Records Access Requirements for Food Facilities |
2022-12-05 |
| 0910-0559 |
Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement |
2004-11-01 |
| 0910-0558 |
Infant Feeding Practices Study II |
2006-03-09 |
| 0910-0557 |
Guidance for Industry - Pharmacogenomic Data Submissions |
2017-07-18 |
| 0910-0555 |
SPresubmission Conferences - Final Rule |
2004-09-01 |
| 0910-0553 |
Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use |
2017-03-15 |
| 0910-0551 |
Application for Participation in the Medical Device Fellowship Program; Form FDA 3608 |
2016-12-08 |
| 0910-0549 |
Irradiation in the Production, Processing and Handling of Food |
2005-04-06 |
| 0910-0548 |
Requirements for Collection of Data Relating to the Prevention of Medical Gas Mix-ups at Health Care Facilities Survey |
2008-08-26 |
| 0910-0546 |
Reporting Associated with Food Additive Petitions, Investigational Food Additive Files Exemptions, and Declaration of Color Additives on Animal Food Labels |
2025-05-16 |
| 0910-0545 |
Health and Diet Survey -- 2004 Supplement |
2017-12-28 |
| 0910-0543 |
Human Cells, Tissues, and Cellular and Tissue-Based Products |
2023-07-13 |
| 0910-0541 |
Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition |
2019-12-05 |
| 0910-0540 |
Guidance for Industry: Animal Drug User Fees and Fee Waivers and Reductions |
2023-09-29 |
| 0910-0539 |
Animal Drug User Fee Cover Sheet |
2017-07-27 |
| 0910-0538 |
Supplements and Other Changes to an Approved Application - Final Rule |
2004-02-09 |
| 0910-0537 |
Bar Code Label Requirements for Human Drug Products and Biological Products (Final Rule) |
2019-07-22 |
| 0910-0533 |
Experimental Study of Trans Fat Claims on Foods |
2007-02-22 |
| 0910-0532 |
Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosures on the Nutrition Facts Panel (NFP) |
2007-03-21 |
| 0910-0531 |
Experimental Study of Health Claim disclaimers on Foods |
2003-11-26 |
| 0910-0530 |
Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format |
2013-09-19 |
| 0910-0529 |
21 CFR Parts 510 and 558 Requirements for Liquid Medicated Animal Feed and Free-Choice Medicated Animal Feed - NPRM |
2003-11-17 |
| 0910-0528 |
Guidance for Industry - Reports on the Status of Postmarketing Studies - Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 |
2003-11-14 |
| 0910-0527 |
Certain Biologics Labeling |
2003-11-03 |
| 0910-0524 |
Guidance for Industry: How to Submit a Protocol Without Data in Electronic Format to the Center for Veterinary Medicine |
2010-04-30 |
| 0910-0523 |
Product Jurisdiction: Assignment of Agency Component for Review of Premarket Applications |
2023-11-30 |
| 0910-0522 |
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern |
2005-07-06 |
| 0910-0521 |
Assessment of the Effects of Antimicrobial Drug Residues from Food of Animal Origin on the Human Intestinal Flora |
2003-10-09 |
| 0910-0520 |
Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 |
2023-08-08 |
| 0910-0519 |
Control of Communicable Diseases; Requests for Exemptions from the Restrictions on African Rodents, Prarie Dogs, and Certain Other Animals |
2007-09-05 |
| 0910-0518 |
Guidance for Industry: Continuous Marketing Applications: Pilot 2 Scientific Feedback and Interactions During Development of Fast Track Products Under PDUFA |
2007-06-28 |
| 0910-0516 |
Impact of Risk Management Programs on the Practice of Pharmacy - Survey |
2003-08-25 |
| 0910-0515 |
Food Labeling: Trans Fatty Acids in Nutrition Labeling |
2006-11-16 |
| 0910-0514 |
Submission of Validation Data for Reprocessed Single-Use Devices |
2003-07-11 |
| 0910-0513 |
Applications for FDA Approval to Market a New Drug: Patient Listing Requirements and Application of 30-month Stays on Approval of Abbreviated New Drug Applications Certifying That... |
2019-09-10 |
| 0910-0511 |
Medical Device User Fee Cover Sheet and Device Facility User Fee Cover Sheet — Form FDA 3601 and Form 3601(a) |
2024-09-30 |
| 0910-0510 |
Medical Devices; Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002 (MDUFMA) |
2021-01-14 |
| 0910-0509 |
Establishing and Maintaining Lists of U.S.Product Manufacturers/Processors With Interest in Exporting CFSAN-Regulated Products |
2025-08-26 |
| 0910-0508 |
MDUFMA Small Business Qualification Certification |
2025-06-12 |
| 0910-0504 |
Revisions to the General Safety Requirements for Biological Products |
2003-03-05 |
| 0910-0502 |
Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 |
2025-09-30 |
| 0910-0501 |
Telephone Questionnaire Administration to Control Subjects Recruited into FDA Lyme Vaccine Safety Study, "A Case-Control Study of HLA Type and T-Cell Reactivity to Recombinat Outer..... |
2002-11-18 |
| 0910-0500 |
Rapid Response Surveys |
2023-08-31 |
| 0910-0498 |
Export Certificates for FDA Regulated Products under U.S.C. Sections 801(e) and 802 |
2024-04-29 |
| 0910-0497 |
Focus Groups as Used by the Food and Drug Administration |
2023-10-31 |
| 0910-0495 |
Food Contact Substance Notification |
2025-12-31 |
| 0910-0494 |
The Evaluation of Long-Term Antibiotic Drug Therapy for Persons Involved in Anthrax Remediation Activities |
2003-04-01 |
| 0910-0493 |
Salmonella Discovery System Pilot Study |
2002-07-30 |
| 0910-0492 |
Consumer Surveys on Food and Dietary Supplement Labeling Issues |
2002-12-19 |
| 0910-0491 |
Shortages Data Collection |
2024-05-20 |
| 0910-0489 |
Health and Diet Survey |
2002-03-14 |
| 0910-0486 |
Requirements for States as Certification Agencies |
2002-02-07 |
| 0910-0485 |
Medical Device Labeling Requirements |
2025-01-07 |
| 0910-0484 |
Suggested Documentation for Demonstrating Compliance with Channels of Trade Provision for Foods with Vinclozolin Residues |
2002-01-25 |
| 0910-0483 |
Foreign Establishment Registration and Listing |
2002-01-25 |
| 0910-0482 |
Exports: Notification and Recordkeeping Requirements |
2025-07-30 |
| 0910-0480 |
Providing Regulatory Submissions in Electronic Format for Food Additive and Color Additive Petitions |
2003-11-20 |
| 0910-0479 |
Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer (DTC) Promotion of Prescription Drugs |
2001-10-04 |
| 0910-0478 |
Consumer and Producer Surveys on Economic Issues |
2003-05-30 |
| 0910-0477 |
Survey of Single-Use Medical Device (SUD) Reuse and Reprocessing in Hospitals |
2001-07-27 |
| 0910-0474 |
General Requirements for Blood, Blood Components, and Blood Derivatives; Donor Notification |
2001-06-15 |
| 0910-0472 |
Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicate Disease Agents; and Requirements for Donor Notification |
2004-07-14 |
| 0910-0471 |
Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) |
2023-06-30 |
| 0910-0470 |
Special Protocol Assessment Guidance |
2020-04-27 |
| 0910-0469 |
Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishments Registration and Listing; Final Rule |
2004-05-28 |
| 0910-0468 |
Focus Group Study of Radiation Disclosure Statement Options for Food Treated with Ionizing Radiation |
2001-05-31 |
| 0910-0467 |
Request for Review of Scientific Disputes Concerning the Regulation of Medical Devices |
2001-02-12 |
| 0910-0466 |
Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing of Juice |
2026-04-30 |
| 0910-0462 |
Regulations on Statements Made for Dietary Supplements Concerning the Effect of the Product on the Structure or Function of the Body; Stay of Act; Effective Date of Final Rule |
2000-12-08 |
| 0910-0461 |
Substances Approved for Use in the Preparatin of Meat and Poultry Products |
2000-11-29 |
| 0910-0459 |
Information Program on Clinical Trials for Serious and Life-Threatening Diseases: Maintaining a Databank |
2007-11-19 |
| 0910-0458 |
Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing |
2023-01-24 |
| 0910-0457 |
Rapid Response Surveys |
2003-05-21 |
| 0910-0456 |
PHS Guideline on Infectious Disease Issues in Xenotransplantation |
2025-07-30 |
| 0910-0455 |
Documentation for demonstrating compliance with the Channels of Trade Provisoin (FFDCA Section 408(I)(5)) |
2001-03-21 |
| 0910-0454 |
Guidance: How to Use E-Mail to Submit Information to the Center for Veterinary Medicine |
2019-10-16 |
| 0910-0453 |
Guidance for Industry on How to Use E-Mail to Submit a Notice of Final Disposition of Invest. Animals Not Intended for Immediate Slaughter |
2010-04-30 |
| 0910-0452 |
Guidance for Industry on How to Use E-Mail to Submit a Request for a Meeting or Teleconference to the Office of New Animal Drug Evaluation |
2010-05-27 |
| 0910-0450 |
Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes in Electronic Format to CVM |
2010-04-30 |
| 0910-0449 |
Postmarket Surveillance of Medical Devices |
2025-12-23 |
| 0910-0448 |
Adoption of FDA Food Code by Local, State, and Tribal Governments |
2010-06-28 |
| 0910-0446 |
Survey of Incidence of gastroenterological Parasitic Infections in the United States as a Result of Consumption of Raw Fish |
2000-10-23 |
| 0910-0445 |
Submitting and Reviewing Complete Responses to Clinical Holds; Guidance for Industry |
2006-12-13 |
| 0910-0444 |
Food additives; Food Contact Substances Notification System |
2002-12-18 |
| 0910-0443 |
Survey of Incidence of Gastroenterolocial Parasitic Infections in the United States as a Result of Consumption of Raw Fish |
2000-05-18 |
| 0910-0442 |
Medical Devices; Device Tracking (Amended) |
2023-12-06 |
| 0910-0439 |
Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition |
2006-05-30 |
| 0910-0437 |
Medical Devices; Medical Reporting; Manufacturer Reporting, Importer Reporting, User Facility Reporting, Distributor Reporting |
2025-07-30 |
| 0910-0435 |
Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements |
2025-03-31 |
| 0910-0433 |
Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Reports |
2004-01-20 |
| 0910-0432 |
Medical Device Recall Authority |
2024-09-26 |
| 0910-0431 |
Changes to an Approved NDA or ANDA |
2001-01-05 |
| 0910-0430 |
Guidance for Industry on Formal Dispute Resolutions; Appeals Above the Division Level |
2019-02-27 |
| 0910-0429 |
Guidance for Industry on Formal Mettings with Sponsors and Applicants for PDUFA Products |
2020-02-13 |
| 0910-0428 |
Record Retention Requirements for the Soy Protein/CHD Health Claim |
2024-06-12 |
| 0910-0427 |
Biological Product Regulated under Section 351 of the Public Health Service Act; Implementation of Biologics License; Elimination of Establishment License and Product License |
2002-08-30 |
| 0910-0426 |
Quality Mammography Standards: Lay Summaries for Patients |
2001-02-28 |
| 0910-0425 |
Survey of Food Manufacturers for Year 2000 Compliance |
1999-10-18 |
| 0910-0423 |
New Drug and Biological Drug Products; Evidence Needed to Demonstrate Efficacy of New Drugs for Use Against Lethal Or Permanently Disabling Toxic Substances When Efficacy Studies.... |
2003-04-01 |
| 0910-0422 |
Survey of Manufacturing Practices in the Dietary Supplement Industry |
1999-10-04 |
| 0910-0417 |
Survey of Biomedical Equipment Manufacturers for Year 2000 Compliance |
1999-08-13 |
| 0910-0416 |
Investigational New Drug Applications and New Drug Applications |
2002-05-28 |
| 0910-0411 |
Study of Manufacturers of Computer-Controlled, Potentially High-Risk Medical Devices Regarding Year 2000 Status |
1999-07-02 |
| 0910-0409 |
Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring |
2024-03-21 |
| 0910-0408 |
Survey of Licensed Biologics Manufacturers and Registered Blood Establishments for Year 2000 Compliance |
1999-05-20 |
| 0910-0405 |
Survey of Medical Device Manufacturers for Year 2000 Compliance of Manufacturing Processes |
1999-05-06 |
| 0910-0402 |
Survey of Drug Manufacturers, Distributors, Repackagers, and Other Drug Distribution Facilities for Year 2000 Compliance |
1999-03-19 |
| 0910-0399 |
Attitudinal and Behavioral Effects of Direct-to-Consumer (DTC) Advertising of Prescription Drugs (Survey) |
1999-01-25 |
| 0910-0398 |
Labeling for Menstrual Tampons; Absorbency Range of 15-18 Grams |
2001-07-18 |
| 0910-0397 |
Survey of Biomedical Equipment Manufacturers for Year 2000 Compliant Products |
1999-01-21 |
| 0910-0396 |
Financial Disclosure by Clinical Investigators -- 21 CFR Part 54 (Final Rule) |
2025-05-05 |
| 0910-0395 |
Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis |
2006-07-11 |
| 0910-0393 |
Prescription Drug Product Labeling; Medication Guide Requirements |
2022-10-31 |
| 0910-0392 |
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients |
2002-07-31 |
| 0910-0391 |
Investigational Device Exemptions, Modifications |
2000-08-23 |
| 0910-0390 |
Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices |
2005-09-28 |
| 0910-0389 |
Guidance for Industry: Fast Track Drug Development Programs; Designation, Development, and Application Review |
2018-02-13 |
| 0910-0388 |
Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly.... |
1998-10-13 |
| 0910-0387 |
Medical Devices Registration and Listing |
2011-04-12 |
| 0910-0385 |
Supplements to Premarket Approval Applications for Medical Devices |
1998-09-01 |
| 0910-0384 |
Medical Devices: Humanitarian Use Devices |
2000-02-23 |
| 0910-0383 |
Access to Mammography Services Survey |
2000-02-23 |
| 0910-0381 |
Food Labeling Regulations |
2024-12-20 |
| 0910-0378 |
Medical Devices; Third-Party Premarket Submission Review and Quality System Inspections Under U.S./E.C. Mutual Recognition Agreement |
2005-01-07 |
| 0910-0376 |
Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use |
2001-07-06 |
| 0910-0375 |
Medical Devices; Third Party Review Under FDAMA |
2025-12-01 |
| 0910-0374 |
Guidance for Industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body |
2015-03-13 |
| 0910-0372 |
Manufacturers of Human Cellular and Tissue-Based Products |
1998-05-04 |
| 0910-0370 |
Specific Requirements on the Content and Format of Labeling for Human Prescription Drugs; Addition of Geriatric Use Subsection |
2004-07-19 |
| 0910-0369 |
Tobacco Retailer Tracking Study |
1999-08-04 |
| 0910-0368 |
OTC Test Sample Collection Systems for Drugs of Abuse Testing - 21 CFR Part 809 |
2003-05-07 |
| 0910-0367 |
Performance Standard for Electrode Lead Wires and Patient Cables: Petitions for Exemptions and Variances |
2000-06-17 |
| 0910-0366 |
Financial Disclosure by Clinical Investigators -- 21 CFR Part 54 (Final Rule) |
1999-08-10 |
| 0910-0365 |
Serving Sizes: Reference Amount for Candies |
2000-10-31 |
| 0910-0364 |
Nutrition Labeling: Declaration of Caloric Amounts and Serving Sizes for Breath Mints |
2001-03-07 |
| 0910-0363 |
Veterinary Feed Directive Distributor Notification |
2024-06-21 |
| 0910-0362 |
Serving Sizes: Reference Amount for Salt, Salt Substitutes, Seasoning Salts (e.g., Garlic Salt) |
1998-10-29 |
| 0910-0361 |
Medical Devices; Classification/Reclassification; Restricted Devices; Analyte Specific Reagents |
2003-05-07 |
| 0910-0360 |
FDA Customer/Partner Satisfaction Surveys |
2023-09-07 |
| 0910-0359 |
Reports of corrections and Removals; 21 CFR Part 806 |
2023-09-05 |
| 0910-0358 |
Tobacco Retailer Tracking Study |
1997-11-21 |
| 0910-0357 |
Serving Sizes: Reference Amount for Baking Powder, Baking Soda, and Pectin |
1997-11-20 |
| 0910-0356 |
Substantial Evidence of Effectiveness of New Animal Drugs |
2007-03-23 |
| 0910-0355 |
Survey of Food Safety Practices of Food Processing Firms |
2000-07-05 |
| 0910-0354 |
Procedures for the Safe Processing and Importing of Fish and Fishery Products; 21 CFR Part 123 |
2023-02-03 |
| 0910-0353 |
Sterility Requirements for Inhalation Solution Products |
2004-03-11 |
| 0910-0352 |
Latex Condoms; User Labeling - Expiration Dating (21 CFR 801.435) |
2003-05-07 |
| 0910-0351 |
Requirements for Nutrition and Ingredient Labeling of Dietary Supplements -- 21 CFR Part 101 (Final Rule) |
1998-10-29 |
| 0910-0349 |
Nutrient Content Claims and Health Claims, Restaurant Foods |
1998-10-29 |
| 0910-0348 |
Medical Devices, Investigational Device Exemptions, Treatment Use |
2000-08-23 |
| 0910-0345 |
Food Safety, Health, and Diet Survey |
2025-09-30 |
| 0910-0343 |
Evaluation of Revised Formats for Over-the-Counter (OTC) Drugs |
1997-05-20 |
| 0910-0342 |
Substances Generally Recognized as Safe: Notification Procedure |
2025-08-26 |
| 0910-0341 |
FDA Safety Communication Readership Survey |
2017-07-12 |
| 0910-0340 |
Over-the-Counter Human Drugs; Labeling Requirements |
2024-12-26 |
| 0910-0339 |
Substances Prohibited from use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed, 21 CFR 589.2000 |
2025-09-30 |
| 0910-0338 |
General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling; and Revocation and Suspension |
2024-09-19 |
| 0910-0337 |
Medicated Feed Mill License Application |
2025-05-12 |
| 0910-0336 |
Current Good Manufacturing Practices for Blood and Blood Components; Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection |
1999-11-08 |
| 0910-0335 |
Gender Differences in Perception of Risks Communicated by Prescription and Over-the-Counter Drug Labels, Survey |
1996-12-27 |
| 0910-0334 |
Notification of Nutrient Content Claims for Fat or Fatty Acids Based on Digestibility Factors |
1999-07-19 |
| 0910-0332 |
Medical Devices; Humanitarian Use Devices; 21 CFR Part 814 - Subpart H |
2025-12-19 |
| 0910-0331 |
Food Labeling; Notification Procedures for Statement on Dietary Supplements |
2025-07-30 |
| 0910-0330 |
Premarket Notification for a New Dietary Ingredient |
2024-01-18 |
| 0910-0325 |
Extralabel Drug Use in Animals -- Proposed Rule |
2024-01-10 |
| 0910-0324 |
Small Business Exemption Notices -- 21 CFR Part 101 |
1996-06-07 |
| 0910-0323 |
Current Good Manufacturing Practice, Proposed Amendment of Certain Requirements for Finished Pharmaceuticals |
1998-04-27 |
| 0910-0322 |
National Environmental Policy Act, Policy and Procedures -- 21 CFR Part 25 (Proposed Rule) |
2025-09-30 |
| 0910-0320 |
Request for Information from U.S. Processors that Export to the European Community |
2017-04-25 |
| 0910-0318 |
Medical Devices; Third-Party Review of Selected Premarket Notifications; Pilot Program |
1996-03-11 |
| 0910-0317 |
Permanent Listing of Color Additive Lakes |
1998-09-13 |
| 0910-0316 |
Well-Characterized Biotechnology Products, Elimination of Establishment License Application |
1997-04-23 |
| 0910-0315 |
General Licensing Provisions: Changes to an Approved Application; Labeling; and Revocation and Suspension |
2002-08-30 |
| 0910-0312 |
Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents |
2026-03-27 |
| 0910-0311 |
Use of Auditory Canal Thermometers in Pediatric and Family practice Offices. |
1995-06-22 |
| 0910-0310 |
Joint FDA/NHLBI Health and Diet Survey, Cycle VI |
1995-06-27 |
| 0910-0309 |
Mammography Standards Quality Act Requirements |
2026-03-27 |
| 0910-0308 |
Biological Products; General records and postmarket adverse experience reporting |
2024-04-26 |
| 0910-0306 |
Pesticide Residue Study of Monthly Rice Production Volumes from Operating U.S. Rice Mills |
1995-01-27 |
| 0910-0305 |
Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions |
2002-05-28 |
| 0910-0303 |
Electronic Records; Electronic Signatures |
2024-01-22 |
| 0910-0302 |
HUMAN TISSUE INTENDED FOR TRANSPLANTATION -- 21 CFR 1270 |
2020-01-24 |
| 0910-0301 |
TISSUE BANK SURVEY |
1994-03-01 |
| 0910-0300 |
FOOD LABEL USE AND NUTRITION EDUCATION SURVEY |
1993-10-25 |
| 0910-0299 |
INVESTIGATIONAL DEVICE EXEMPTIONS, DISQUALIFICATION OF CLINICAL INVESTIGATORS (PROPOSED RULE) |
1993-10-22 |
| 0910-0298 |
Threshold of Regulation for Substances Used in Food-Contact Articles |
2022-12-08 |
| 0910-0297 |
User Fee Cover Sheet |
2025-06-18 |
| 0910-0296 |
MEDICAL DEVICE INNOVATION SURVEY |
1993-08-30 |
| 0910-0293 |
MEDICAL DEVICE RECALL COST SURVEY |
1993-12-01 |
| 0910-0291 |
MedWatch: The FDA Medical Products Reporting Program |
2026-04-13 |
| 0910-0290 |
NATIONAL SURVEY OF PHYSICIANS CONCERNING PERCEPTIONS OF DRUG PRODUCT LABELING AND THE BRIEF SUMMARY |
1993-04-12 |
| 0910-0289 |
NEW ANIMAL DRUG REGULATIONS -- 21 CFR PART 514 (PROPOSED RULE) |
1995-09-30 |
| 0910-0288 |
FOOD LABELING: NUTRIENT CONTENT CLAIMS, GENERAL PRINCIPLES, PETITIONS, DEFINITION OF TERMS, DEFINITIONS OF NUTRIENT CONTENT CLAIMS FOR THE FATTY ACID & CHOLESTEROL CONTENT, ETC |
1993-02-24 |
| 0910-0287 |
FOOD LABELING: GENERAL REQUIREMENTS FOR HEALTH CLAIMS FOR FOOD -- 21 CFR PART 101 |
1993-02-04 |
| 0910-0286 |
Reference Amount Petitions -- 21 CFR 100.12(h) |
1998-10-29 |
| 0910-0284 |
RECORDS AND REPORTS CONCERNING EXPERIENCE WITH NEW ANIMAL DRUGS FOR WHICH AN APPROVED APPLICATION IS IN EFFECT -- 21 CFR PART 514 (PROPOSED RULE) |
2026-05-26 |
| 0910-0282 |
INFANT FEEDING PRACTICES SURVEY |
1992-11-09 |
| 0910-0281 |
Medical Devices: Substantial Equivalence, 510(k) Summaries and 510(k) Statements Premarket Notification |
1999-07-19 |
| 0910-0280 |
CONSUMER FOOD HANDLING PRACTICES AND AWARENESS OF MICROBIOLOGICAL HAZARDS |
1992-08-28 |
| 0910-0279 |
Year 2004 Updates on the National Survey of Prescription Drug Information Provided to Patients |
2004-06-17 |
| 0910-0277 |
STATE PETITIONS REQUESTING EXEMPTION FROM FEDERAL PREEMPTION 21 CFR PART 100 (NPRM) |
2023-11-30 |
| 0910-0275 |
STATE ENFORCEMENT PROVISIONS OF THE NUTRITION LABELING AND EDUCATION ACT OF 1990 -- 21 CFR PART 101 (NPRM) |
2024-06-18 |
| 0910-0271 |
STUDY OF FOOD LABEL FORMATS: PHASE II |
1991-07-15 |
| 0910-0268 |
STUDY OF FOOD LABEL FORMATS - MAIN STUDY |
1990-10-25 |
| 0910-0267 |
WEIGHT LOSS PRACTICES SURVEY |
1990-04-17 |
| 0910-0266 |
JOINT FDA/NHLBI HEALTH AND DIET SURVEY, CYCLE V |
1990-02-12 |
| 0910-0265 |
FOOD LABELING COST SURVEY |
1989-10-25 |
| 0910-0264 |
EXPORT OF MEDICAL DEVICES: FOREIGN LETTER OF APPROVAL |
2025-09-11 |
| 0910-0263 |
READERSHIP EVALUATION OF THE FDA DRUG BULLETIN |
1989-07-31 |
| 0910-0262 |
COSMETIC RISK ASSESSMENT: EXPOSURE SURVEY |
1994-04-01 |
| 0910-0261 |
AUTOMATIC DETENTION AND PRIVATE LABORATORY TESTING OF FDA-REGULATED PRODUCTS FOR IMPORT ENTRY |
1992-02-28 |
| 0910-0260 |
TREATMENT OF NARCOTIC ADDICTS, JOINT REVISION OF CONDITIONS FOR USE, INTERIM MAINTENANCE TREATMENT -- 21 CFR PART 291 |
1993-01-19 |
| 0910-0259 |
TEA CHOP LIST AND APPELLANT'S APPLICATION FOR REVIEW OF EXAMINER'S RETURN |
1991-05-07 |
| 0910-0258 |
APPLICATION FOR AUTHORIZATION TO RELABEL OR TO PERFORM OTHER ACTIONS |
1989-06-26 |
| 0910-0257 |
MENSTRUAL TAMPONS: USER LABELING, PROPOSED RANGES OF ABSORBENCY: 21 CFR 801.430(2), (F) - NPRM |
1990-01-07 |
| 0910-0256 |
Infant Formula Requirements |
2025-06-03 |
| 0910-0255 |
INTERNAL ANALGESIC, ANTIPYRETIC, ANTIRHEUMATIC DRUG PRODUCTS FOR OTC HUMAN USE - NPRM |
1989-01-24 |
| 0910-0254 |
LABEL DECLARATIONS: CHOLESTEROL CONTENT OF FOODS (NPRM) |
1989-08-03 |
| 0910-0253 |
MEDICAL DEVICE CONFORMANCE ASSESSMENT TO VOLUNTARY STANDARDS |
1992-07-16 |
| 0910-0251 |
PRESCRIPTION DRUG MARKETING ACT OF 1987, GUIDELINES FOR STATE LICENSING OF WHOLESALE DRUG DISTRIBUTORS - NPRM |
2022-02-22 |
| 0910-0250 |
LABELING REQUIREMENTS FOR SULFITING AGENTS IN STANDARDIZED FOODS - NPRM 21 CFR 130 |
1991-01-02 |
| 0910-0249 |
FDA RECALL REGULATIONS, 21 CFR PART 7, SUBPART C |
2024-04-30 |
| 0910-0248 |
SURVEY OF JAPANESE PHARMACEUTICAL FIRMS REGARDING NEW BIOTECHNOLOGY PRODUCTS |
1988-08-08 |
| 0910-0247 |
HUMAN FACTORS REGARDING THE USE OF GLUCOSE MONITORING EQUIPMENT |
1989-06-27 |
| 0910-0245 |
SURVEY OF CONSUMER FOOD-HANDLING PRACTICES AND AWARENESS OF MICROBIOLOGICAL HAZARDS |
1990-04-09 |
| 0910-0242 |
Aspartame as an Inactive Ingredient in Human Drug Products, Labeling Requirements |
1995-09-20 |
| 0910-0241 |
SURVEY TO DETERMINE PATIENT KNOWLEDGE AND PERCEPTIONS ON HEMODIALYSIS REUSE |
1987-10-01 |
| 0910-0240 |
JOINT FDA/NHLBI/NCI HEALTH AND DIET SURVEY, CYCLE IV |
1987-08-26 |
| 0910-0238 |
DECLARATION OF NET QUANTITY |
1989-11-07 |
| 0910-0237 |
BRONCHODILATOR DRUG PRODUCTS FOR OTC HUMAN USE |
1990-02-15 |
| 0910-0235 |
Foreign Language Disclosure Labeling |
1995-09-20 |
| 0910-0234 |
CARDIAC PACEMAKER REGISTRY - NPRM |
1994-03-11 |
| 0910-0233 |
Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions |
2023-03-30 |
| 0910-0232 |
ANTHELMINTIC DRUG PRODUCTS FOR OTC HUMAN USE |
1995-09-20 |
| 0910-0231 |
Premarket Approval of Medical Devices; 21 CFR Part 814 |
2023-03-30 |
| 0910-0230 |
Postmarketing Adverse Drug Experienced Reporting - 21 CFR 310.305 and 314.80 |
2025-01-23 |
| 0910-0229 |
APPROVAL OF BULK NEW ANIMAL DRUG SUBSTANCES FOR USE BY LICENSED VETERINARIANS - NPRM |
1989-04-10 |
| 0910-0228 |
SPONSORED COMPOUNDS IN FOOD-PRODUCING ANIMALS, CRITERIA AND PROCEDURES FOR EVALUATING THE SAFETY OF CARCINOGENIC RESIDUES - NPRM |
1992-04-14 |
| 0910-0227 |
TEST FOR ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) -- 21 CFR 640 |
1993-05-27 |
| 0910-0226 |
INTERNATIONAL DRUG SCHEDULING, CONVENTION ON PSYCHOTROPIC SUBSTANCES, NON-BARBITURATE SEDATIVES - VOLUNTARY SUBMISSION OF DATA AND COMMENTS ON THE ABUSE POTENTIAL, ACTUAL ABUSE... |
1988-11-07 |
| 0910-0225 |
EXOCRINE PANCREATIC INSUFFICIENCY DRUG PRODUCTS FOR OTC HUMAN USE - TENTATIVE FINAL RULE - NPRM |
1989-06-14 |
| 0910-0224 |
CHOLESTEROL, FAT AND FATTY ACIDS LABELING, 21 CFR PART 101 |
1989-06-08 |
| 0910-0223 |
LABELING OF IMITATION FOODS |
1989-06-28 |
| 0910-0222 |
COMMON OR USUAL NAME: LABELING OF PEANUT SPREADS (21 CFR PART 102) |
1989-06-28 |
| 0910-0221 |
FOLLOW UP OF GROWTH HORMONE RECIPIENTS |
1986-03-20 |
| 0910-0220 |
INFANT FEEDING PRACTICES STUDY |
1991-06-04 |
| 0910-0219 |
STANDARDS SURVEY |
1999-07-19 |
| 0910-0218 |
LABELING OF WEIGHT CONTROL FOODS |
1989-08-18 |
| 0910-0216 |
Color Additive Requests and Recordkeeping |
2023-10-23 |
| 0910-0215 |
QUICK TURNAROUND RESEARCH SERVICES - FDA 1986 MULTIPURPOSE SURVEY |
1985-07-08 |
| 0910-0213 |
SPECIFIC PRODUCT REQUIREMENTS, ELECTRONIC PRODUCTS |
2000-12-07 |
| 0910-0212 |
REGULATIONS UNDER THE FEDERAL IMPORT MILK ACT, 21 CFR PART 1210 |
2024-07-26 |
| 0910-0211 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF HUMAN T-LYMPHOTROPIC VIRUS FOR IN-VITRO DIAGNOSTIC USE |
1989-01-04 |
| 0910-0210 |
PROPOSED RULE - ADVERSE DRUG EXPERIENCE REPORTING REQUIREMENTS FOR MARKETED PRESCRIPTION DRUGS WITHOUT APPROVED NEW DRUG OR ABBREVIATED NEW DRUG APPLICATIONS |
1986-06-24 |
| 0910-0209 |
ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS, PROPOSED AMENDMENTS OF REQUIREMENTS FOR BLOOD GROUPING SERUM-NPRM |
1985-03-06 |
| 0910-0208 |
ADDITIONAL STANDARDS FOR ANTI-HUMAN GLOBULIN - 21 CFR 660 SUBPART F |
1989-12-18 |
| 0910-0207 |
LAXATIVE DRUG PRODUCTS FOR OTC HUMAN USE - NPRM |
1987-11-18 |
| 0910-0206 |
REQUEST FOR SAMPLES AND PROTOCOLS, OFFICIAL RELEASE 21 CFR 610.2 |
2021-08-27 |
| 0910-0205 |
NEW ANIMAL DRUG REQUIREMENTS FOR MEDICATED FREE-CHOICE FEEDS 21 CFR 510.455 |
1991-06-21 |
| 0910-0204 |
EXPORT OF INVESTIGATIONAL NEW ANIMAL DRUGS, TENTATIVE FINAL RULE |
1984-11-09 |
| 0910-0203 |
GOOD LABORATORY PRACTICE REGULATIONS FOR NONCLINICAL LABORATORY STUDIES |
1984-10-31 |
| 0910-0201 |
MEDICAL DEVICE REPORTING |
1990-10-17 |
| 0910-0200 |
LABELING - FOODS AND COSMETICS |
1984-07-27 |
| 0910-0198 |
FOOD LABELING: DECLARATION OF SODIUM CONTENT OF FOODS AND LABEL CLAIMS FOR FOODS ON THE BASIS OF SODIUM CONTENT 21 CFR PART 101 |
1989-05-04 |
| 0910-0197 |
"REQUEST FOR EXTENSION OF COMMENT PERIOD" |
1987-06-26 |
| 0910-0196 |
GENERAL STANDARD OF IDENTITY FOR "CERTAIN OTHER CHEESES', NPRM, 21 CFR PART 133 |
1989-07-25 |
| 0910-0195 |
LABELING REQUIREMENTS FOR MEDICAL DEVICES AND RADIOLOGICAL PRODUCTS |
1984-04-04 |
| 0910-0194 |
Petition for Administrative Stay of Action -- 21 CFR 10.35 |
2003-04-14 |
| 0910-0193 |
ADVISORY OPINIONS -- 21 CFR 10.85 |
2000-01-10 |
| 0910-0192 |
PETITION FOR ADMINISTRATIVE RECONSIDERATION OF ACTION -- 21 CFR 10.33 |
2003-04-14 |
| 0910-0191 |
Notice of Participation -- 21 CFR 12.45 |
2023-09-06 |
| 0910-0190 |
NATIONAL ENVIRONMENTAL POLICY ACT: POLICIES AND PROCEDURES 21 CFR PART 25 |
1994-08-16 |
| 0910-0188 |
Infant Formula Recall Regulations -- 21 CFR Part 107 |
2020-11-27 |
| 0910-0187 |
LABELING REQUIREMENTS FOR HUMAN DRUGS, BIOLOGICS AND VETERINARY DRUGS |
1984-02-24 |
| 0910-0186 |
IRRADIATION IN THE PRODUCTION, PROCESSING, AND HANDLING OF FOOD -- 21 CFR PART 179 |
2024-06-12 |
| 0910-0185 |
Labeling Requirements for Color Additives (Other Than Hair Dyes) and Petitions (Formerly Color Additive Petitions) |
2003-11-20 |
| 0910-0184 |
FILING OF OBJECTIONS AND REQUESTS FOR HEARING ON A REGULATION OR ORDER |
2012-03-30 |
| 0910-0183 |
General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions |
2014-06-12 |
| 0910-0182 |
Use of Impact-Resistant Lenses in Eyeglasses and Sunglasses |
2001-03-05 |
| 0910-0181 |
REQUEST FOR CERTIFICATION OF AN INSULIN BATCH |
1992-07-29 |
| 0910-0179 |
INFANT FORMULA QUALITY CONTROL PROCEDURES |
1992-04-08 |
| 0910-0178 |
FOOD AND DRUG ADMINISTRATION FY '84 CONSUMER FOOD SURVEY |
1983-12-02 |
| 0910-0177 |
NUTRITION LABELING, 21 CFR 101.9 (B) & (C) |
1989-04-24 |
| 0910-0176 |
LASER PRODUCTS, PROPOSED AMENDMENTS TO PERFORMANCE STANDARD (NPRM) |
1994-10-06 |
| 0910-0171 |
Hearing Aid Devices: Professional and Patient Labeling and Conditions for Sale |
2002-03-29 |
| 0910-0168 |
Shipment of a Blood Product Prior to Completion of Testing for Products Known Reactive for HBsAg |
2001-09-17 |
| 0910-0167 |
Orphan Products Development; Common European Medicines Agency/FDA Form for Orphan Medicinal Product Designation and FDA Orphan Drug Designation Request Form |
2025-05-05 |
| 0910-0164 |
PRESCRIPTION DRUG ADVERTISING TO CONSUMERS STUDY |
1983-07-29 |
| 0910-0163 |
MEDICATED FEED APPLICATION - NPRM |
1983-07-26 |
| 0910-0162 |
INVESTIGATIONAL NEW DRUG APPLICATION |
1984-01-26 |
| 0910-0161 |
ALLERGENIC PRODUCTS, LIST OF SOURCE MATERIALS |
1992-10-27 |
| 0910-0159 |
INFANT FORMULA, LABELING REQUIREMENTS |
1983-07-13 |
| 0910-0158 |
EXEMPT INFANT FORMULA |
1989-07-21 |
| 0910-0155 |
REPORTING REQUIREMENTS APPLICABLE TO NORMAL SERUM ALBUMIN AND PLASMA PROTEIN FRACTION |
1983-10-27 |
| 0910-0154 |
Good Manufacturing Practice Regulations for Type A Medicated Articles, 21 CFR Part 226 |
2023-06-29 |
| 0910-0152 |
GOOD MANUFACTURING PRACTICE REGULATIONS FOR MEDICATED FEEDS, RECORD-KEEPING REQUIREMENTS |
2023-07-31 |
| 0910-0151 |
TEMPORARY EXEMPTIONS FROM CERTAIN FOOD LABELING REQUIREMENTS FOR PURPOSE OF CONDUCTING AUTHORIZED FOOD LABELING EXPERIMENTS -- 21 CFR 101.108(B) |
1995-09-30 |
| 0910-0150 |
TAMPER RESISTANT PACKAGING REQUIREMENTS FOR CONTACT LENS SOLUTIONS AND TABLETS |
1989-06-28 |
| 0910-0149 |
Tamper-Resistant Packaging Requirements for OTC Human Drug Products |
1995-09-20 |
| 0910-0148 |
FORMALDEHYDE CLEARINGHOUSE DATA FORM |
1982-10-26 |
| 0910-0147 |
FDA FY '82 CONSUMER SURVEY |
1982-07-29 |
| 0910-0145 |
QUANTITY AND NATURE OF PATIENT INTERACTIONS WITH PHYSICIANS AND PHARMACISTS RE: PRESCRIPTIONS |
1982-06-07 |
| 0910-0144 |
STATE AGENCY OPINION SURVEY |
1981-12-21 |
| 0910-0143 |
MEDICAL DEVICE AND LABORATORY PRODUCT PROBLEM REPORTING PROGRAM |
1992-11-30 |
| 0910-0141 |
PHYSICIAN RESPONSE TO REDUCED INFORMATION REQUIREMENTS IN PRESCRIPTION DRUG ADVERTISING |
1981-11-20 |
| 0910-0140 |
REPORTING AND RECORDKEEPING REQUIREMENTS IMPOSED BY THE METHADONE REGULATIONS |
1998-02-25 |
| 0910-0139 |
GMPS FOR FINISHED PHARMACEUTICALS, MEDICATED FEEDS AND MEDICATED PREMISES |
2023-09-28 |
| 0910-0138 |
Reclassification Petitions for Medical Devices |
2024-12-20 |
| 0910-0137 |
REPORTING REQUIREMENTS APPLICABLE TO THE MFG. OF NORMAL SERUM ALBUMIN, PLASMA PROTEIN FRACTION AND BLOOD GROUPING SERUM |
1984-12-28 |
| 0910-0136 |
REPORTING REQUIREMENTS APPLICABLE TO SHIPMENT OF HEPATITIS REACTIVE PRODUCTS |
1987-03-30 |
| 0910-0135 |
RECORDKEEPING REQUIREMENTS FOR EXEMPTION FROM FDA APPROVAL FOR NEW DRUGS USED IN NONHUMAN RESEARCH |
1986-04-08 |
| 0910-0134 |
REPORTING AND RECORDKEEPING REQUIREMENTS APPLICABLE TO THE EXEMPTIONS FROM ANTIBIOTIC CERTIFICATION AND LABELING PROGRAM |
1981-10-30 |
| 0910-0133 |
Temporary Marketing Permit Applications |
2023-12-01 |
| 0910-0132 |
PETITIONS OF AFFIRMATION OF GENERALLY RECOGNIZED AS SAFE (GRAS) SUBSTANCES -- 21 CFR PART 170 |
2003-11-20 |
| 0910-0131 |
Agreement for Shipments of Devices for Sterilization |
2025-09-25 |
| 0910-0130 |
Protection of Human Subjects; Recordkeeping Requirements for Institutional Review Boards (IRBs) |
2023-11-27 |
| 0910-0129 |
Applications for Exemption from Preemption of Medical Device Requirements |
2003-04-21 |
| 0910-0128 |
MEASURING TIMELINESS AND RESPONSIVENESS OF LETTERS TO CONSUMERS |
1983-06-13 |
| 0910-0127 |
NATIONAL CONSUMER AWARENESS AND ACCESS PROJECT EVALUATION |
1981-04-28 |
| 0910-0126 |
SURVEY OF SMALL MANUFACTURERS (REGULATORY FLEXIBILITY) |
1981-04-13 |
| 0910-0124 |
LICENSE APPLICATIONS FOR THE MFG. OF ALLERGENICS AND PLASMA DERIVATIVES PRODUCTS AND GENERAL ESTABLISHMENT |
2000-09-15 |
| 0910-0120 |
Premarket Notification Submission 5100(k), Subpart E |
2023-08-28 |
| 0910-0119 |
Good Laboratory Practices (GLP) Regulations for Nonclinical Laboratory Studies -- 21 CFR Part 58 |
2023-12-19 |
| 0910-0117 |
New Animals Drugs for Investigational Use -- 21 CFR Part 511 |
2024-07-10 |
| 0910-0116 |
GOOD MANUFACTURING PRACTICES FOR BLOOD NAND BLOOD COMPONENTS |
2023-08-30 |
| 0910-0115 |
BUREAU OF MEDICAL DEVICES STANDARDS SURVEY |
1983-01-17 |
| 0910-0114 |
ADMINISTRATIVE DETENTION RECORDKEEPING REQUIREMENTS |
2025-06-25 |
| 0910-0112 |
FY '80 MULTI-PURPOSE FOOD SURVEY |
1980-10-22 |
| 0910-0111 |
PHYSICIAN INTERPRETATION OF RESEARCH DATA |
1981-05-30 |
| 0910-0110 |
POISON CONTROL QUESTIONNAIRE - PART I |
1980-05-09 |
| 0910-0106 |
NATIONAL SURVEY OF CHEST X-RAY SCREENING POLICIES |
1979-09-06 |
| 0910-0105 |
CONSUMER COMPREHENSION OF OTC DRUG LABELING |
1980-11-12 |
| 0910-0101 |
UTILIZATION, QUALITY ASSURANCE, AND TRAINING PRACTICES OF COMPUTED TOMOGRAPHY FACILITIES |
1980-04-15 |
| 0910-0098 |
NUCLEAR MEDICINE QUALITY ASSURANCE SURVEY |
1980-12-16 |
| 0910-0097 |
SURVEY OF NUTRITION VOCABULARY AND QUANTITATIVE DECLARATIONS |
1979-12-20 |
| 0910-0096 |
SPECIAL DIETARY FOODS SURVEY |
1980-06-06 |
| 0910-0091 |
EFFECTS OF PPIS AS A FUNCTION OF CRITICAL VARIATIONS |
1979-07-05 |
| 0910-0083 |
NEXT IMAGE RECEPTOR MODULE |
1979-08-20 |
| 0910-0081 |
A FOLLOW-UP STUDY OF PERSONS WHO HAD 131 IODINE AND OTHER THYROID TESTS |
1978-05-04 |
| 0910-0079 |
SOURCE PLASMA (HUMAN) AMENDMEND TO STORAGE TEMPERATURE REQUIREMENTS |
1980-07-29 |
| 0910-0078 |
Investigational Device Exemptions Reports and Records -- 21 CFR 812 |
2026-02-27 |
| 0910-0077 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURERS OF WHOLE BLOOD AND BLOOD COMPONENTS |
1989-06-28 |
| 0910-0076 |
MEDICATED FEED APPLICATION FDA-1900 |
1980-04-22 |
| 0910-0075 |
OBLIGATIONS OF SPONSORS AND MONITORS OF CLINICAL INVESTIGATIONS |
1980-04-09 |
| 0910-0074 |
COLOR ADDITIVE PETITION |
1980-03-10 |
| 0910-0073 |
Quality System Regulation Amendments |
2024-03-20 |
| 0910-0072 |
PERFORMANCE STANDARDS DEVELOPMENT |
1989-04-26 |
| 0910-0071 |
RADIATION INCIDENTS REGISTRY REPORTING PROGRAM ELECTRONIC PRODUCT RADIATION |
1982-04-07 |
| 0910-0070 |
REIMBURSEMENT FOR PARTICIPATION IN ADMINISTRATIVE PROCEEDINGS |
1980-07-28 |
| 0910-0069 |
RADIATION EXPERIENCE DATA STUDY |
1982-03-11 |
| 0910-0068 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURER OF SINGLE DONOR PLASMA |
1979-07-27 |
| 0910-0067 |
INTRAOCULAR LENS INVESTIGATIONAL DEVICE EXEMPTION APPLICATION |
1991-06-17 |
| 0910-0066 |
INVESTIGATIONAL SHIPMENT OF IN VITRO DIAGNOSTIC DEVICES |
1983-09-08 |
| 0910-0065 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF ANTI-HUMAN GLOBULIN SERA |
1986-09-02 |
| 0910-0064 |
HIGH-YIELD CRITERIA FORM |
1978-08-14 |
| 0910-0063 |
USER EXPERIENCES WITH EXTENDED-WEAR AND OTHER TYPES OF CONTACT LENSES |
1986-09-22 |
| 0910-0062 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF REAGENT RED BLOOD CELLS |
1986-12-10 |
| 0910-0061 |
PRODUCTS LICENSE APPLICATION FOR THE MANUFACTURE OF BLOOD GROUPING SERUM |
1989-04-12 |
| 0910-0060 |
MEDICAL DEVICE REGISTRATION DATE RECEIVED 10/03/85 |
1988-11-10 |
| 0910-0059 |
Medical Devices: Medical Device Reporting, User Facility Reporting, Manufacturer Reporting, Certification, Registration (Final Rule) |
2000-04-10 |
| 0910-0058 |
BLOOD SAMPLE IDENTIFICATION CARD |
1981-06-29 |
| 0910-0057 |
MEDICAL DEVICE LISTING |
1989-06-28 |
| 0910-0055 |
NEW DRUG AND ANTIBIOTIC REGULATIONS |
1985-02-22 |
| 0910-0054 |
ASHP/FDA DRUG SHORTAGE MONITORING PROGRAM |
1982-06-30 |
| 0910-0053 |
REPORT OF RESEARCH USE OF RADIOACTIVE DRUG MEMBERSHIP SUMMARY; STUDY SUMMARY |
2023-08-14 |
| 0910-0052 |
REGISTRATION OF BLOOD AND BLOOD PRODUCT ESTABLISHMENT |
2024-06-28 |
| 0910-0051 |
DECLARATION FOR PRODUCTS SUBJECT TO RADIATION CONTROL STANDARDS |
1981-07-17 |
| 0910-0050 |
STATE AGENCY TELECOMUNICATIONS LOG |
1977-10-31 |
| 0910-0049 |
ANNUAL REVIEW OF STATE AND LOCAL RADIOLOGICAL HEALTH PROGRAMS |
1981-12-01 |
| 0910-0048 |
Notice of Availability of Sample Electronic Product |
1997-09-26 |
| 0910-0047 |
COSMETIC PRODUCT EXPERIENCE REPORTS -- 21 CFR PART 730 |
1995-03-07 |
| 0910-0046 |
Imports and Electronic Import Entries |
2024-08-19 |
| 0910-0045 |
Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution |
2026-03-16 |
| 0910-0044 |
HOSPITAL REQUEST FOR METHADONE FOR DETOXIFICATION AND TEMPORARY MAINTENANCE TREATMENT |
1978-01-05 |
| 0910-0043 |
APPLICATION FOR APPROVAL OF USE OF METHADONE IN A TREATMENT PROGRAM |
1980-11-28 |
| 0910-0042 |
MEDICAL RESPONSIBILITY STATEMENT FOR USE OF METHADONE IN A TREATMENT PROGRAM |
1980-11-28 |
| 0910-0041 |
ESTABLISHMENT LICENSE APPLICATION FOR THE MANUFACTURE OF BLOOD AND BLOOD COMPONENTS |
1986-05-23 |
| 0910-0040 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF SOURCE PLASMA |
1989-06-28 |
| 0910-0039 |
TRANSMITTAL OF LABELS AND CIRCULARS FOR BIOLOGICAL PRODUCTS |
1997-09-25 |
| 0910-0038 |
THE CONFERENCE OF RADIATION CONTROL PROGRAMS DIRECTORS NATIONWIDE EVALUATION OF XRAY TRENDS SURVEY FORM |
1981-07-17 |
| 0910-0037 |
Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers |
2023-10-12 |
| 0910-0036 |
REPORTING AND RECORDKEEPING REQUIREMENTS FOR LOW-ACID AND ACIDIFIED CANNED FOOD PROCESSORS |
1989-11-16 |
| 0910-0035 |
FOOD CANNING AND PROCESS FILING FOR OTHER THAN STILL RETORT AND AGITATING PROCESSES |
1977-08-08 |
| 0910-0034 |
FOOD CANNING ESTABLISHMENT AND PROCESS FILING FOR AGITATING PROCESSES |
1977-09-15 |
| 0910-0033 |
FOOD CANNING ESTABLISHMENT AND PROCESS FILING FOR STILL RETO RT PROCESSES |
1977-09-15 |
| 0910-0032 |
SPONSORED COMPOUNDS IN FOOD-PRODUCING ANIMALS, CRITERIA AND PROCEDURES FOR EVALUATING THE SAFETY OF CARCINOGENIC RESIDUES - NPRM (ANIMAL DRUY SAFETY POLICY) |
2025-12-01 |
| 0910-0031 |
COSMETIC RAW MATERIAL COMPOSITION STATEMENT |
1989-06-05 |
| 0910-0030 |
Cosmetic Product Voluntary Reporting Program -- 21 CFR Part 770 |
2008-12-18 |
| 0910-0029 |
NOTICE OF DISCONTINUANCE OF COMMERCIAL DISTRIBUTION OF COSMETIC PRODUCT OR COSMETIC RAW MATERIAL |
1989-01-11 |
| 0910-0028 |
REPORT OF ASSEMBLY OF A DIAGNOSTIC X-RAY SYSTEM OR SUBSYSTEM (REGULATIONS AND REPORT FORM) |
1978-07-12 |
| 0910-0027 |
Voluntary Registration of Cosmetics Product Establishment |
2017-08-22 |
| 0910-0026 |
DRUG EXPERIENCE REPORT (SHORT FORM) |
1980-06-30 |
| 0910-0025 |
REQUIREMENTS UNDER PUBLIC LAW 90-602, RADIATION CONTROL FOR HEALTH AND SAFETY ACT OF 1968 |
2026-02-27 |
| 0910-0024 |
PROBLEM REPORTING PROGRAM FOR DRUGS AND RADIOPHARMACEUTICALS |
1992-07-09 |
| 0910-0023 |
POISONING REPORT AND POISON CONTROL INFORMATION RECORD |
1984-06-27 |
| 0910-0022 |
SHELLFISH CERTIFICATION CANCELLATION |
1984-09-10 |
| 0910-0021 |
SHELLFISH CERTIFICATION |
2025-06-26 |
| 0910-0020 |
RESOURCE DATA FOR STATE FOOD AND DRUG PROGRAMS |
1992-08-05 |
| 0910-0019 |
TRANSMITTAL OF PERIODIC REPORTS AND PROMOTIONAL MATERIAL FOR NEW ANIMAL DRUGS -- 21 CFR PART 510 |
1994-11-02 |
| 0910-0018 |
TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING FOR HUMAN USE |
1982-07-16 |
| 0910-0017 |
TRANSMITTAL OF PERIODIC REPORTS FOR DRUGS FOR HUMAN USE |
1984-10-31 |
| 0910-0016 |
Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions, and Electronic Submission Using FDA Form 3503 |
2023-09-21 |
| 0910-0015 |
STATEMENT OF INVESTIGATOR (CLINICAL PHARMACOLOGY) |
1983-07-14 |
| 0910-0014 |
NOTICE OF CLAIMED INVESTIGATIONAL EXEMPTION FOR NEW DRUG |
2025-12-02 |
| 0910-0013 |
STATEMENT OF INVESTIGATOR |
1983-07-14 |
| 0910-0012 |
VETERINARY DRUG EXPERIENCE REPORT |
2003-03-21 |
| 0910-0011 |
MEDICATED FEEED APPLICATION (21 CFR 514.2) |
1995-09-30 |
| 0910-0010 |
APPLICATION FOR COMMISSION (STATE OFFICIALS TO ACT AS AGENTS FOR FDA) |
1987-04-30 |
| 0910-0009 |
REQUEST FOR SUPPLEMENTAL CERTIFICATION OF A BATCH OF ANTIBIOTIC DRUGS |
1983-09-15 |
| 0910-0008 |
APPLICATION FOR EXEMPTION FOR REPACKING OF ANTIBIOTICS |
1980-02-28 |
| 0910-0007 |
REQUEST FOR CERTIFICATION OR TESTING OF AN ANTIBIOTIC BATCH |
1989-06-28 |
| 0910-0006 |
APPLICATION FOR EXEMPTION FOR MANUFACTURING USE OF ANTIBIOTICS |
1979-11-14 |
| 0910-0005 |
APPLICATION FOR EXEMPTION FOR LABELING OF ANTIBIOTIC DRUGS |
1979-11-07 |
| 0910-0004 |
APPLICATION FOR EXEMPTION FOR PROCESSING OF ANTIBIOTIC DRUGS |
1979-11-07 |
| 0910-0003 |
APPLICATION FOR EXEMPTION FOR STORAGE OF ANTIBIOTIC DRUGS |
1979-11-07 |
| 0910-0002 |
DRUG EXPERIENCE REPORT (ON EFFECTS OF DRUG USAGE) |
1984-08-23 |
| 0910-0001 |
NEW DRUG APPLICATION |
2025-12-31 |